Previous studies have shown that SPP2 inhibits the growth of tumor cells in prostate cancer [10], pancreatic cancer [9] and hepatocellular carcinoma [11] and attenuates the growth-enhancing effects of BMP2. Here, SPP2 is linked to prostate cancer.